The BioNanoMedicine Center “NANOMIB” of the University Milano-Bicocca is a biotech platform whose mission is the design, synthesis and validation of nano-devices for regenerative medicine, therapy and diagnosis of human diseases.
Nanomib accelerates the path that goes from laboratory experimentation to the application of new methods in humans diagnostic and therapeutics of many diseases that are still largely untreated today: “from the bench to the bedside” promoting an effective link with pharmaceutical and medical industries. The Center brings together the skills of Milano-Bicocca researchers in various research areas (chemistry, materials, physics, biophysics, biochemistry, biology, physiology, biotechnology, informatics, statistics, toxicology, and almost all clinical specializations) and different Departments (Medicine and Surgery, Biotechnology and Biosciences, Physics, Materials Science Informatics , Environmental and Earth Sciences) to create new models of care and prevention in the field of therapy, diagnostics and regenerative medicine.

The activities of the Center are reflected in scientific publications, participation in national and international research projects, participation in national and international Conferences and – in the field of technology transfer- patenting, patent licensing and creation of Spin-Offs. The researchers of the Center are also involved in formation of human capital within the PhD program in Translational medicine with a track in  Nanomedicine , and within the PhD program in Nanostructures and Nanotechnologies.

Courses of “Nanomedicine” are also given by the researchers of the Center within the Master degrees of “ Industrial Technology” and “Medical biotechnologies”